Showing results (611-620 of 638) with videos related to

Sort By:
Pageof 64
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonGrant P Parnell, Prudence N Gatt, Fiona C McKay, et al.
Arthritis and Rheumatism|October 2, 2002
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosisEbun Aganna, Fabio Martinon, Philip N Hawkins, et al.
Scientific Reports|May 30, 2019
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.
The Journal of Clinical Investigation|June 15, 1996
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI geneD R Booth, S Y Tan, S E Booth, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonRussell C Dale, Esther M Tantsis, Vera Merheb, et al.
Human Molecular Genetics|March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesisKaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.
Nature Genetics|September 15, 2009
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapyVijayaprakash Suppiah, Max Moldovan, Golo Ahlenstiel, et al.
Genes and Immunity|April 19, 2013
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infectionV Suppiah, N J Armstrong, K S O'Connor, et al.
Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.
Pageof 64